000			02012 a2200601 4500
005			20250517103856.0
264		0	_c20180223
008			201802s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.10354 _2doi
040			_aNLM _beng _cNLM
100	1		_aKang, Joon Hee
245	0	0	_aAldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion. _h[electronic resource]
260			_bOncotarget _cAug 2016
300			_a49397-49410 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAction Potentials
650	0	4	_aAdenosine Triphosphate _xmetabolism
650	0	4	_aAldehyde Dehydrogenase _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aAspartic Acid _xmetabolism
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCytosol _xmetabolism
650	0	4	_aFemale
650	0	4	_aGossypol _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMalates _xmetabolism
650	0	4	_aMembrane Potential, Mitochondrial
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aMitochondria _xmetabolism
650	0	4	_aNAD _xmetabolism
650	0	4	_aNADP _xmetabolism
650	0	4	_aNeoplasm Transplantation
650	0	4	_aOxidative Phosphorylation
650	0	4	_aOxidoreductases Acting on CH-NH Group Donors
650	0	4	_aPhenformin _xadministration & dosage
650	0	4	_aRNA, Small Interfering _xmetabolism
700	1		_aLee, Seon-Hyeong
700	1		_aLee, Jae-Seon
700	1		_aNam, Boas
700	1		_aSeong, Tae Wha
700	1		_aSon, Jaekyoung
700	1		_aJang, Hyonchol
700	1		_aHong, Kyeong Man
700	1		_aLee, Cheolju
700	1		_aKim, Soo-Youl
773	0		_tOncotarget _gvol. 7 _gno. 31 _gp. 49397-49410
856	4	0	_uhttps://doi.org/10.18632/oncotarget.10354 _zAvailable from publisher's website
999			_c26197054 _d26197054